Because TGF-β signaling activation leads to the accumulation of Prdm16 through the suppression of Smad4 inhibitory effects, one would speculate that Smad4 and Prdm16 might function in the same signaling network that integrates the TGF-β tumor promoter effects during PDAC progression. This evidence concerns the gene TGFB1 and neoplasm.